Pre-tax Impact of GAAP to Non-GAAP Adjustments Included in Condensed Consolidated Unaudited Statements of Operations | |||||
|
| |||||
(In thousands) | Acquisition - Related
|
| Restructuring,
|
| Total Pre-tax GAAP
|
Three Months Ended March 31, 2023 |
|
|
|
|
|
Costs of revenues | $ 45,437 |
| $ 6,039 |
| $ 51,476 |
Research and development | — |
| 6,664 |
| 6,664 |
Selling, general and administrative | 19,613 |
| 6,386 |
| 25,999 |
Total in three months ended March 31, 2023 | $ 65,050 |
| $ 19,089 |
| $ 84,139 |
Three Months Ended Dec. 31, 2022 |
|
|
|
|
|
Costs of revenues | $ 45,437 |
| $ — |
| $ 45,437 |
Research and development | 748 |
| — |
| 748 |
Selling, general and administrative | 20,504 |
| — |
| 20,504 |
Total in three months ended Dec. 31, 2022 | $ 66,689 |
| $ — |
| $ 66,689 |
Three Months Ended March 31, 2022 |
|
|
|
|
|
Costs of revenues | $ 42,576 |
| $ — |
| $ 42,576 |
Selling, general and administrative | 17,322 |
| — |
| 17,322 |
Other expense (income), net | — |
| 2,513 |
| 2,513 |
Total in three months ended March 31, 2022 | $ 59,898 |
| $ 2,513 |
| $ 62,411 |
Free Cash Flow Reconciliation | |||||||
|
| |||||||
|
| Three Months Ended March 31, |
| Nine Months Ended March 31, | ||||
(In thousands) | 2023 |
| 2022 |
| 2023 |
| 2022 |
| Net cash provided by operating activities | $ 1,010,855 |
| $ 818,878 |
| $ 2,710,690 |
| $ 2,493,473 |
| Capital expenditures | (84,914) |
| (100,304) |
| (262,908) |
| (234,160) |
| Free cash flow | $ 925,941 |
| $ 718,574 |
| $ 2,447,782 |
| $ 2,259,313 |
|
| |||||||
|
| |||||||
| Capital Returns Calculation | |||||||
|
| |||||||
|
| Three Months Ended March 31, |
| Nine Months Ended March 31, | ||||
| (In thousands) | 2023 |
| 2022 |
| 2023 |
| 2022 |
| Payments of dividends to stockholders | $ 180,854 |
| $ 158,976 |
| $ 553,046 |
| $ 480,926 |
| Common stock repurchases | 478,186 |
| 564,666 |
| 923,039 |
| 1,394,217 |
| Capital returns | $ 659,040 |
| $ 723,642 |
| $ 1,476,085 |
| $ 1,875,143 |
